Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy
Sundararaman Swaminathan(Post Graduate Institute of Medical Education and Research), Nelson Leung(WinnMed), Matthew D. Griffin(Hebei Medical University), Mark R. Pittelkow(Mayo Clinic in Arizona), Iftikhar Ahmed(West Hertfordshire Hospitals NHS Trust), Noel M. Caplice(University College Cork), Robert C. Albright(Mayo Clinic), James T. McCarthy(Mayo Clinic)
Cited by 126
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657